Home

Medical Devices made of substances: opportunities and challenges

Special Issue

The Medical Device (MD) Regulation was officially published in Europe May on 5th, 2017 (https://eurlex.europa.eu/legalcontent/EN/TXT/?uri=CELEX:020...

Official Statement of the section of Clinical Pharmacology of the Italian Society of Pharmacology on the use of ACE- inhibitors or angiotensin receptor blockers in COVID-19 infection with commentary

Letter to the Editor

The coronavirus 2019 (SARS-CoV-2) pandemic is spreading around the world and is a matter of great concern. In this situation, it is more important ...

Official Statement of the section of Clinical Pharmacology of Italian Society of Pharmacology on Non-steroidal anti-inflammatory drugs (NSAIDs) and the increased risk of complications during infections with commentary

Letter to the Editor

On March 16th, 2020, the French Minister of Health has recommended the use of paracetamol for the treatment of fever in patients with suspected of ...

Angiotensin-converting enzyme-2 (ACE2): New opportunity or red herring?

Short Article

Since early December 2019 when the first pneumonia cases of unknown origin were identified in Wuhan, the COVID-19 outbreak has been expanding from ...

The contribution of the clinical laboratory to the new medicine paradigm

Research Article

Our interaction with the clinical analysis laboratory likely began before birth, with blood tests monitoring the evolution of our mother’s pregnanc...

Independent Research in Italy

Opinion Paper

Italy’s indicators for research show contradictory performance. Italian governments have been investing significantly less in terms of GDP than oth...

Treatment of chronic pain in Italy: therapeutic appropriacy of opioids and fear of addiction. The situation in Italy vs. USA

Research Article

Introduction Chronic pain is considered to be one of the most debilitating and expensive pathologies in Europe, North America and Australia. In Eur...